The efficacy and the mode ofaction of pretransplant transfusion with class I major histocompatibility complex (MHC)-disparate splenocytes in establishing a state of peripheral tolerance in adult mice is analyzed. Adult mice injected intravenously with a critical number of N5 x 10' allogenic splenocytes accept skin grafts and develop chimerism in the peripheral lymphatic tissues, but not in thymus and bone marrow. In parallel, a split tolerance evolves : the frequency of class I MHC-reactive Lyt-2+ cytotoxic T lymphocyte precursor (CTIrp)-and interleukin 2 (IIr2)-producing T cells falls off in the peripheral lymphoid tissue, but remains unaltered intrathymically. In particular, high affinity CTLp become clonally undetectable . In vivo generation of tolerant cells is cyclosporin A resistant, but dependent on recipient L3T4+ T cells. Loss of Lyt-2+ CTIrpand IL-2-producing T cell precursors is not due to active suppression, but is caused by clonal anergy. Donor-derived chimeric cells positively selected 7 d after intravenous transfusion exhibit in vitro the hallmarks of veto cells, i.e., paralyze CTLp reactive to donor-type class I MHC alloantigens . We conclude that the peripheral (split) tolerance induced in vivo by pretransplant transfusion operates because donor-type cells develop in vivo efficiently into "veto cells;' which in turn induce a state of clonal anergy within antigen-reactive Lyt-2+ T lymphocytes.
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A prime aim in transplantation immunology is to define gentle methods able to convert immune reactivity to transplantation antigens into a state of immune unresponsiveness. This conversion is successful in neonates: introduction of foreign antigens into a developing immune system prevents the system from responding further on to these antigens (1, 2) . Recent evidence indicates that both in natural tolerance and in experimentally induced neonatal unresponsiveness maturing antigen-reactive thymocytes become either clonally deleted (3) (4) (5) (6) (7) (8) or at least clonally silenced (9) (10) (11) .
Induction of unresponsiveness in a mature peripheral T cell pool meets difficulties : receptor occupancy by antigens primarily induces sensitization rather than tolerization (12) (13) (14) . Therefore, most strategies attempt first to reduce the pool of immunocompetent peripheral T lymphocytes, and thereafter to induce unresponsiveness by exposing the regenerating (neonatal) immune system to antigen . In the first step, rather invasive techniques are used, such as whole body (15, 16) or total lymphoid irradiation (17) , systemic application of antiproliferative drugs (18, 19) , or a combination of either of these methods.
Evaluation of pretransplant transfusion effects have indicated that intravenous confrontation with allogeneic cells may induce specific immunosuppression rather than sensitization (20) (21) (22) (23) (24) (25) (26) (27) (28) . Independently, Miller, Bevan, and associates (29) (30) (31) (32) (33) (34) (35) (36) pioneered the veto cell concept . Accordingly, unlinked to the specificity of their own antigen receptor, veto cells paralyze in vitro the response of T cells reacting to antigens displayed by the veto cells (29) (30) (31) (32) (33) (34) (35) (36) . Interestingly, upon intravenous transfusion of allogeneic lymphocytes (23) (24) (25) (26) (27) (28) or even MHCtransfected recipient cells (37) , recipient mice develop a state of specific unresponsiveness as if the transfused lymphocytes were veto cells. Since intravenous cell transfusion represents a gentle method, and, in addition, bears the promise to induce unresponsiveness in peripheral mature T cells, we have analyzed the efficacy of this approach in vitro and in vivo. The main findings described here are that: (a) injected mice develop a long lasting chimerism that is paralleled by an unresponsiveness to skin allografts; (b) injected mice display a state of split tolerance (i.e., peripheral but not intrathymic CTL precursors (CTLp)t bearing high affinity tolerogen-reactive TCRs are clonally silenced) ; (c) L3T4+ recipient T cells are necessary for tolerance induction; and (d) donor-derived lymphocytes isolated from chimeric recipients display in vitro effective veto functions.
Materials and Methods
Mice. Breeding pairs of C57B1/6 (B6) (H2KbIAbIEbDb), B6.C.H26-' (bml) (H2K6'"'IAblEbDb), B6.C.H2 6m'z (bm12) (H2KbIAbm' 2IEbDb) mice were obtained from The Jackson Laboratory, Bar Harbor, ME. B1l1.BR (H2K'IAkIEkDk) and B10.A (H2KklAkIEkDd) mice were purchased from OLAC, Blackthorn, UK. CB17 (H2K`IAdIEdDd) mice were bred in the animal facility ofthe Ulm University. The mica: were used at an age of 8-12 wk.
Reagents. Human rI1r2 was a kind gift from Eurocetus, Amsterdam, The Netherlands (batch no. LP-370B). Con A was obtained from Pharmacia Fine Chemicals, Uppsala, Sweden . Cyclosporine A (CsA) was generously provided by Dr. Borel, Sandoz AG, Basel, Switzerland. CsA (1 mg) was dissolved in 100 I4l C2H50H and 20 j.1 Tween 80 (Sigma Chemical Co., Munich, FRG). A stock solution (1 mg/ml) was prepared by adding 880,ul PBS. Mice received 20 mg/kg body weight daily intraperitoneally. Selected rabbit low-tox complement was purchased from Cederlane, Hornby, Canada. Rat IgG was purchased from Sigma Chemical Co. PEcoupled streptavidin was from Becton Dickinson & Co., Heidelberg, FRG.
mAbs. FITC-conjugated anti-Lyt-2 antibodies and biotincoupled anti-L3T4 and antiThy-1.2 antibodies were obtained from Becton Dickinson & Co., and used for cell sorter analyses. Hybridomas GK-1.5 (anti-L3T4, a kind gift from Dr. Fitch, University of Chicago), 53-6.72 (anti-Lyt-2 ; American Type Culture Collection, Rockville, MD), HO-13-4 (antiThy-1.2; American Type Culture Collection), and 34-4-20S (anti-H2Dd ; American Type Culture Collection) were grown as ascites. mAbs were purified from ascites fluid using standard methods (38) . Anti-Dd antibodies were coupled with FITC to a FITC/protein ratio of 2 using the method of Goding (39) .
Cell Staining and Cytofluorometry. For analyses, 2-5 x 101 cells were incubated with the respective mAb for 30 min at 4°C. Thereafter, the cells were washed twice with PBS, and, when necessary, a second incubation with PE-coupled streptavidin was performed . Subsequently, the cells were fixed with paraformaldehyde. 1-3 x 104 cells were analyzed with an Epics V cell sorter (Coulter Immunology, Hialeah, FL) . Cells were gated on forward angle light scatter, and the green (FITC) and red (PE) fluorescence was recorded. For cell sorting, 10' cells were stained and sorted according their fluorescence intensity. The purity ofthe sorted population exceeded 98% when reanalyzed.
Complement Lysis. Splenocytes (10'/ml) were incubated for 30 min on ice with the respective antibody. After washing twice with PBS, the cells were incubated at 37°C with a 1:10 dilution ofrabbit low-tox complement (Cederlane) for 30 min. This procedure was repeated twice. Cell sorter analyses revealed that the efficacy ofcomplement lysis was >98%.
Cell Preparation . Thymi and spleens were removed aseptically and then teased. The cell suspension was freed from erythrocytes by a brief incubation in NH4C1 . Spleen cells were always passed over a nylon wool column.
Limiting Assayfor IL2 Activity and Cytotoxicity. IL2 activity in the supernatant of LD cultures was assayed after restimulation with 2 x 105 irradiated (100 Gy) (41) stimulator cells using a colorimetric assay (41, 42) . The "Cr release assay was performed as described (40) .
Statistical Analyses. In LD analyses, all cultures generating cytotoxicity or containing IIr2 exceeding the mean values plus three times the SD ofcultures containing only stimulator cells were considered positive. Calculation offrequencies (f), 95% confidence limits of the frequencies (95% CL), and probabilities of single hit kinetics (p) were performed as described (40) .
Skin Grafting. Mice were anesthetized with pentobarbital (0.6 mg/10 g mouse weight). Tail skin grafts (5 x 5 mm) were then transplanted onto the left chest wall according to the method of Brent et al. (43) . Skin grafts were scored for viability three times a week.
Results
Transfusion with MHC Class I-Disparate Splenocytes Alters T Cell Reactivity. Upon intravenous injection of spleen cells from bml mice into adult B6 recipients, the in vivo and in vitro reactivity of recipient mice changes dramatically. The majority of B6 recipients receiving 5 x 107 allogeneic bm1 spleen cells tolerated bml skin grafts for >4 wk. As detailed in Fig. 1 A, the cell number injected was critical for the induction of unresponsiveness in vivo. In vitro, the frequency of anti-bml-reactive CTLp in the recipient spleen dropped from 1:513 (control) to 1:10,500 within 8 d (Fig. 1 B) . This frequency reduction compares well with the loss of antigenreactive CTLp observed in neonatally induced tolerance to class I MHC antigens (9) (10) (11) . Reduction ofanti-bml-reactive CTLp occurred rapidly within 24 h, peaked at day 10-20, lasted for at least 4 wk ( Fig. 1 C) , and was antigen specific, since the frequency of third party-reactive CTIrp remained unaltered (data not shown) . Fig. 1 D further details that the selective reduction of anti-bml-reactive T cells was not confined to CTLp, but also included anti-bm-l-reactive II, 2-producing T cells. Using cell sorter-purified Lyt-2+ T cells from recipient mice, we found that it is this subset that developed specific unresponsiveness (vide infra) . Essentially similar results were obtained in the B10.A -" B10.BR combination (H-21)d difference) .
Not Thymic, but Peripheral CTLp Become Affected. Next, the frequency of anti-bml-reactive purified thymic Lyt-2+ L3T4 -T cells was compared with that of peripheral T cells 7 d after intravenous injection of 5 x 107 bml spleen cells into B6 recipients . While in peripheral T cells, the frequency of anti-bml-reactive CTLp was reduced to -18% ofthe con- __. 500^6 i .V .
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trol ( Fig . 2 A) , the number of thymic CTLp remained unaffected (Fig. 2 B) . We also analyzed whether the few remaining anti-bmlreactive CTLp in the peripheral T cell pool of tolerant B6 mice could be scored as high affinity or low affinity CTLp. To this, LD cultures were set up and clonally developing CTL colonies (probability for clonality >80%) were assayed for lytic activity towards bml targets in the presence or absence of blocking anti-Lyt-2 mAb (44) . As detailed in Fig . 3 A, 7 of 30 (23%) colonies from splenic T cells of normal B6 mice were able to lyse bml targets in the presence of Lyt-2 mAb, and thus have to be scored as T cells bearing high affinity TCRs (44) . On the other hand, no high affinity anti-bmlreactive CTLp were found in the spleen of tolerant B6 mice. (Fig . 3 B) .
In Vivo Tolerance Induction of Lyt-2 + T Cells Is L3 T4+ T CellDependent, but CsA Resistant. In vivo injection of L3T4-, Lyt-2-, or even Thy-1.2-depleted splenic bml cells into B6 recipients was almost equally effective in causing a selective loss of anti-bml-reactive CTLp (Fig. 4) . On the other hand, recipient L3T4 + T cells were necessary for in vivo induction of tolerance. Thus, B6 mice injected intraperitoneally with 2 mg of anti-L3T4 mAb to deplete their L3T4+ T cells (45) (46) (47) retained their ability to reject bml skin grafts ( Fig. 5) , and the frequency of anti-bml-reactive CTirp was altered only marginally (Table 1) . These results cannot be explained by the assumption that donor L3T4+ T cells in the inoculum were critical for tolerance induction, since L3T4+ T cell-depleted splenocytes are effective in inducing CTIrp reduction (Fig. 4) . Thus, these results imply that recipient L3T4+ T cells are essential for tolerance induction .
CsA inhibits not only lymphokine transcription and secretion in T cells (48) , but also TCR-mediated signals down-
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Veto Cell-Mediated Tolerance In Vivo stream from IIT2R expression during primary activation of resting T cells (40, 49, 50) . Since induction of tolerance is antigen specific at the clonal level, and thus likely to be channeled via the TCR/T3 complex, we anticipated that CsA would interfere with tolerance induction in the model system studied here. However, the results given in Fig. 6 ). About 50-60% of these donor cells expressed the Thy-1.2 T cell marker (Table 3) .
Upon depletion, by cell sorting, of donor cells from the spleen of tolerant mice, the recipient B10.BR T cells remained unresponsive towards donor-type stimulator cells (Table 4) . Thus, unresponsiveness of recipient T cells is not due to active suppression by donor T cells, but represents a state of unresponsiveness due to either functional or clonal deletion. This type of result also extends to donor-derived B10.A lymphocytes from tolerized mice. As detailed in Table 5 , B10.A cells positively selected from chimeric (tolerant) mice contained X10-fold reduced frequencies of antirecipient (Dk)-reactive CTITp.
Even though donor lymphocytes were found to be tolerant, i.e., clonally depleted for antirecipient (anti-Dk) -reactive CTIrp, the very same cells efficiently suppressed the primary activation of CTIrp with reactivity to donor class I MHC antigens; i.e., expressed veto cell function . For example, when B10.A (donor) cells that were positively selected from spleens of $10.BR (recipient) mice 7 d after intravenous injection of B10.A spleen cells were subsequently mixed at a ratio of 1:1 with normal B10.$R splenic responder cells, and thereafter cocultured at limiting dilution with 3 x 105 irradiated B10.A stimulator cells, a biphasic LD curve is obtained. At high cell input (>1,000 veto cells), the frequency of anti-B10.Areactive CTIrp is effectively reduced (Fig. 7 A; Table  6 , biphasic curve II), while at low cell numbers (<1,000 cells), the frequency remained unaltered (Fig. 7 A, biphasic curve  I) . Thus, as few as 1,000 veto cells are sufficient to block in LD cultures the primary activation of naive B10.BR CTIrp reactive to MHC antigens also expressed on veto cells. This suppression was antigen specific, since the reactivity to thirdparty antigens was not affected (Fig. 7 B; Table 6 ). Donorderived B10.A cells from chimeric mice appear to be enriched for veto function, because B10.A cells from normal mice failed to suppress anti-B10.A responses in vitro (Table 6 ).
Discussion
The results described here will be discussed in the context of pretransplant transfusion effects (20) (21) (22) (23) (24) (25) (26) (27) (28) , the veto cell phenomenon first described by Miller and associates (29) (30) (31) (32) (33) (34) (35) (36) , and the concept of peripheral tolerance as opposed to tolerance induced by intrathymic clonal deletion ofantigen-reactive T lymphocytes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) to active suppression, but due to clonal paralysis of antigenreactive Lyt-2+ CTIrp-and 11,2-producing Lyt-2+ T cells . Since donor lymphocytes exhibit clonal anergy to recipient class I MHC antigens, yet express in vitro remarkably efficient veto functions, we believe that the reciprocal peripheral tolerance in the adult chimeric mice is caused, and maintained, by veto activity of donor and recipient cells. Deletion of recipient L3T4+ T cells before pretransplant transfusion abrogates the ability of the recipient to be tolerized ( Fig. 5 ; Table 1 ) . Although establishment of tolerance to class I MHC antigens by pretransplant transfusion meets difficulties if the transfused allogeneic lymphocytes in addition are class II MHC incompatible (26, 27 , unpublished data), a problem that is overcome by systemic application of anti-L3T4 mAb (27) , our data, in addition, imply that recipient L3T4+ cells are essential for the in vivo development of veto cell-dependent peripheral tolerance. Recipient L3T4+ T cells might interact with MHC class II-expressing donor veto cells directly, or might support the activation of veto functions by actively participating in the in vivo response to class I MHC antigens via lymphokine secretion . Assuming the latter, why then is the generation of veto cell activity resistant to the effects of cyclosporine A known to block not only lymphokine transcription and secretion, but also primary activation of resting T cells? In ongoing experiments, we are analyzing whether systemic application of defined recombinant lymphokines such as IIr2 can restore the ability of L3T4+ T cell-deficient adult mice to become tolerized by pretransplant transfusion. We show that pretransplant transfusion results in a state of split tolerance, i.e., high affinity TCRs bearing peripheral, but not thymic, CTIrp become functionally deleted . This contrasts to neonatally induced tolerance, in which thymic and bone marrow chimerism develops (9) . Since in the adult mouse chimerism induced by pretransplant transfusion fades with time, an effect that is paralleled by the reappearance of tolerogen-reactive CTIrp and IL2-producing T lymphocyte precursor (Ilr2 TIrp) (Fig. 1, C and D) , we presently investigate conditions to induce a stable, long-lasting chimerism by bone marrow grafting as well.
In the model system ofneonatal tolerance, removal ofdonorderived cells revealed the existence of anti-donor-reactive T cells (10, 11, 51) . No evidence for active suppression was obtained in the model system detailed here (Table 4 ). Yet, unlike naive donor type cells, donor type cells selected 7 d after transfusion efficiently vetoed primary CTL responses in vitro ( Fig. 7; Table 6 ), as if they were enriched for veto cells . Obviously, these cells are the candidates for the cells that adoptively transferred tolerance in vivo, as recently reported by Martin and Miller (28) .
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Since there is evidence that in vitro veto cells do not clonally delete antigen-reactive T cells, but rather induce paralysis that can be overcome within time (unpublished data), we anticipate the continuous existence of clonally silenced CTIrp in adult mice transfused with class I MHC-incompatible splenic cells. The availability of TCR transgenic mice (7, 8) will allow us to experimentally approach this question . There is already evidence that neonatal tolerization for reactivity to Mls antigens phenotypically abolishes anti-Mls reactivity in vitro and in vivo without clonally deleting the respective Vii-bearing lymphocytes (52) .
Even though there are numerous indications that pretransplant transfusion can induce specific immunosuppression rather than sensitization (20) (21) (22) (23) (24) (25) (26) (27) (28) , the results presented here provide compelling evidence that pretransplant transfusion-induced peripheral tolerance to class I MHC antigens is associated with the in vivo activation and selection ofremarkably efficient veto cells . Opposing thymic deletion of antigen-reactive T cells as a basis for negative selection of maturing T lymphocytes (4-8), veto cells operating in peripheral tolerance clonally appear to silence mature Lyt-2 * T cells. If so, then the in vivo induction and maintenance of tolerance to MHC class I antigens by veto cells might represent a paradigm for natural peripheral tolerance to self-antigens not present in the thymus. Accordingly, veto cells control the reactivity towards endogenously produced proteins and peptides, and might thus be further involved in immunoregulatory networks . On the other hand, pretransplant transfusion represents a gentle procedure to "open the window" of unresponsiveness in adult mice for the establishment of conditions for inducing a stable chimerism that then would imply an indefinitive state oftransplantation tolerance against foreign MHC alloantigens. 
